Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant (NCT04104438) | Clinical Trial Compass
CompletedPhase 4
Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant
United States71 participantsStarted 2021-01-15
Plain-language summary
This is a study to help understand how well new combinations of immunosuppressive medications (medications that weaken your immune system to prevent your body from rejecting the transplanted liver) work compared to standard immunosuppressive medications after your liver transplant. Also the study will assess how safe the new combination of immunosuppressive medicines are and if there are any changes in how your kidneys work after taking these medicines.
Who can participate
Age range18 Years – 78 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. A signed informed consent prior to patient participation in the study and before any assessment is performed.
✓. Patients who are able to take oral medication.
✓. 18 years old
✓. Undergoing first OLT
✓. Dialysis for 45 days or less at time of transplant
✓. Able and willing to conform to requirements of the study